|
Volumn 76, Issue 6, 2015, Pages e835-e836
|
Dr Miskowiak and colleagues reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LITHIUM;
RECOMBINANT ERYTHROPOIETIN;
ERYTHROPOIETIN;
BIPOLAR DISORDER;
COGNITION;
COGNITIVE DEFECT;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG POTENTIATION;
FOLLOW UP;
HAMILTON DEPRESSION RATING SCALE;
HUMAN;
LETTER;
MILD COGNITIVE IMPAIRMENT;
NERVE CELL PLASTICITY;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SIGNAL TRANSDUCTION;
TREATMENT DURATION;
YOUNG MANIA RATING SCALE;
COGNITION DISORDERS;
FEMALE;
MALE;
BIPOLAR DISORDER;
COGNITION DISORDERS;
ERYTHROPOIETIN;
FEMALE;
HUMANS;
MALE;
|
EID: 84932626262
PISSN: 01606689
EISSN: 15552101
Source Type: Journal
DOI: 10.4088/JCP.15lr09809a Document Type: Letter |
Times cited : (1)
|
References (4)
|